EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Synergistic Remodeling of Tumor Immune Microenvironment via a DNA Nanodevice Integrating STING Activation and Lysosome‐Targeted PD‐L1 Degradation

Haoxiang Li, Min Hou, Shasha Sun, Jun Cao, Jian-Hui Jiang iD, Jianjun He iD

Advanced Science · 2026-08 · 13 (47)

DOI: 10.1002/advs.75855 ↗

At a glance

Journal article in Advanced Science, published online on 2026-05-27. Written by Haoxiang Li and 5 co-authors. Institution: School of Biomedical Sciences, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan Unive…. Major MEDLINE topics: Tumor Microenvironment, B7-H1 Antigen, Lysosomes, Membrane Proteins. Cited 1 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science and Technology Innovation Program of Hunan Province, Key Fundamental Research Program Hunan Province, Scientific Research Program of FuRong Laboratory.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The cGAS‐STING pathway is a cornerstone of innate antitumor immunity; however, its therapeutic potential is often limited by the inefficient cytosolic delivery of agonists and the immunosuppressive tumor microenvironment (TME). Here, we report a DNA nanostructure‐based platform that simultaneously induces lysosomal degradation of immune checkpoint protein PD‐L1 and activates the STING pathway. We demonstrate that STING activation further enhances PD‐L1 degradation, resulting in strong synergistic immune activation. In murine models of triple‐negative breast cancer, the DNA nanodevice effectively reprograms the TME by enhancing dendritic cell maturation and CD8 + T cell infiltration, resulting in potent suppression of both primary tumor growth and pulmonary metastases. This study establishes a versatile nanoplatform that bridges targeted protein degradation with STING‐mediated innate immune activation, provides a promise strategy for cancer immunotherapy.

Subjects

MeSH terms (MEDLINE)

Tumor MicroenvironmentB7-H1 AntigenLysosomesMembrane ProteinsTriple Negative Breast NeoplasmsAnimalsMiceSTING ProteincGAS-STING Signaling PathwayFemaleHumansDNA NanostructuresImmunotherapyCell Line, TumorDendritic Cells

Author keywords

CGAS‐STINGimmunotherapytargeted protein degradationtumor microenvironmenttumor treatment

Substances

B7-H1 AntigenMembrane ProteinsSTING ProteinSting1 protein, mouseSTING1 protein, human

Authors and institutions

  • School of Biomedical Sciences, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.
  • School of Physics and Chemistry, Hunan First Normal University, Changsha, China.
  • FuRong Laboratory, Changsha, China.

ORCID profiles: Jian-Hui Jiang, Jianjun He

Funding

  • Science and Technology Innovation Program of Hunan Province
  • Key Fundamental Research Program Hunan Province
  • Scientific Research Program of FuRong Laboratory

Cite

APA

Li, H., Hou, M., Sun, S., Cao, J., Jiang, J. H., & He, J. (2026). Synergistic Remodeling of Tumor Immune Microenvironment via a DNA Nanodevice Integrating STING Activation and Lysosome‐Targeted PD‐L1 Degradation. Advanced Science, 13(47). https://doi.org/10.1002/advs.75855

Vancouver

Li H, Hou M, Sun S, Cao J, Jiang JH, He J. Synergistic Remodeling of Tumor Immune Microenvironment via a DNA Nanodevice Integrating STING Activation and Lysosome‐Targeted PD‐L1 Degradation. Advanced Science. 2026;13(47). doi:10.1002/advs.75855

BibTeX
@article{Li2026,
  author = {Li, Haoxiang and Hou, Min and Sun, Shasha and Cao, Jun and Jiang, Jian-Hui and He, Jianjun},
  title = {Synergistic Remodeling of Tumor Immune Microenvironment via a DNA Nanodevice Integrating STING Activation and Lysosome‐Targeted PD‐L1 Degradation},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {47},
  doi = {10.1002/advs.75855}
}
Start for free →